Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 61

1.

How complement activation influences the development of chronic synovitis in a mouse model of rheumatoid arthritis.

Belenska-Todorova L, Gyurkovska V, Ivanovska N.

Scand J Rheumatol. 2015 Jul 23:1-10. [Epub ahead of print]

PMID:
26202173
2.

Kinase inhibitors with redox and anti-inflammatory activities.

Ivanovska N, Saso L, Dimitrov P.

Curr Top Med Chem. 2015;15(9):872-85.

PMID:
25697562
3.

Tyrosine kinase inhibitor tyrphostin AG490 reduces liver injury in LPS-induced shock.

Gyurkovska V, Ivanovska N.

Eur J Pharmacol. 2015 Mar 15;751:118-26. doi: 10.1016/j.ejphar.2015.01.045. Epub 2015 Feb 7.

PMID:
25666385
4.

Acetylated derivative of glaucine inhibits joint inflammation in collagenase-induced arthritis.

Gyurkovska V, Philipov S, Kostova N, Ivanovska N.

Immunopharmacol Immunotoxicol. 2015 Feb;37(1):56-62. doi: 10.3109/08923973.2014.972414. Epub 2014 Oct 20.

PMID:
25328086
5.

TLR2 elicits IL-17-mediated RANKL expression, IL-17, and OPG production in neutrophils from arthritic mice.

Milanova V, Ivanovska N, Dimitrova P.

Mediators Inflamm. 2014;2014:643406. doi: 10.1155/2014/643406. Epub 2014 Mar 16.

6.

Septicaemia models using Streptococcus pneumoniae and Listeria monocytogenes: understanding the role of complement properdin.

Dupont A, Mohamed F, Salehen N, Glenn S, Francescut L, Adib R, Byrne S, Brewin H, Elliott I, Richards L, Dimitrova P, Schwaeble W, Ivanovska N, Kadioglu A, Machado LR, Andrew PW, Stover C.

Med Microbiol Immunol. 2014 Aug;203(4):257-71. doi: 10.1007/s00430-013-0324-z. Epub 2014 Apr 12.

7.

Tyrosine kinase inhibitor tyrphostin AG490 retards chronic joint inflammation in mice.

Gyurkovska V, Stefanova T, Dimitrova P, Danova S, Tropcheva R, Ivanovska N.

Inflammation. 2014 Aug;37(4):995-1005. doi: 10.1007/s10753-014-9820-6.

PMID:
24473905
8.

The effect of interleukin 17 and Toll-like receptor 2 on CD11b expression and apoptosis of neutrophils in zymosaninduced arthritis and paw oedema.

Milanova V, Ivanovska N, Dimitrova P.

Cent Eur J Immunol. 2014;39(2):131-41. doi: 10.5114/ceji.2014.43712. Epub 2014 Jun 27.

9.

Harpagoside: from Kalahari Desert to pharmacy shelf.

Georgiev MI, Ivanovska N, Alipieva K, Dimitrova P, Verpoorte R.

Phytochemistry. 2013 Aug;92:8-15. doi: 10.1016/j.phytochem.2013.04.009. Epub 2013 May 1.

PMID:
23642455
10.

Abrogated RANKL expression in properdin-deficient mice is associated with better outcome from collagen-antibody-induced arthritis.

Dimitrova P, Ivanovska N, Belenska L, Milanova V, Schwaeble W, Stover C.

Arthritis Res Ther. 2012 Jul 25;14(4):R173. doi: 10.1186/ar3926.

11.

Pro-inflammatory action of Candida albicans DNA in zymosan-induced arthritis.

Dimitrova P, Danova S, Ivanovska N.

Inflamm Res. 2012 Jun;61(6):649-56. doi: 10.1007/s00011-012-0457-3. Epub 2012 Mar 4.

PMID:
22391624
12.

Antiinflammatory properties of extracts and compounds isolated from Verbascum xanthophoeniceum Griseb.

Dimitrova P, Kostadinova E, Milanova V, Alipieva K, Georgiev M, Ivanovska N.

Phytother Res. 2012 Nov;26(11):1681-7. doi: 10.1002/ptr.4641. Epub 2012 Mar 3.

PMID:
22389249
13.

Bone resorption and remodeling in murine collagenase-induced osteoarthritis after administration of glucosamine.

Ivanovska N, Dimitrova P.

Arthritis Res Ther. 2011 Mar 16;13(2):R44. doi: 10.1186/ar3283.

14.

Involvement of soluble receptor activator of nuclear factor-κB ligand (sRANKL) in collagenase-induced murine osteoarthritis and human osteoarthritis.

Dimitrova P, Toncheva A, Gyurkovska V, Ivanovska N.

Rheumatol Int. 2012 May;32(5):1317-25. doi: 10.1007/s00296-010-1723-8. Epub 2011 Feb 3.

PMID:
21290130
15.

The role of properdin in murine zymosan-induced arthritis.

Dimitrova P, Ivanovska N, Schwaeble W, Gyurkovska V, Stover C.

Mol Immunol. 2010 Apr;47(7-8):1458-66. doi: 10.1016/j.molimm.2010.02.007. Epub 2010 Mar 11.

PMID:
20226532
16.

Toll-like receptor-mediated anti-inflammatory action of glaucine and oxoglaucine.

Remichkova M, Dimitrova P, Philipov S, Ivanovska N.

Fitoterapia. 2009 Oct;80(7):411-4. doi: 10.1016/j.fitote.2009.05.016. Epub 2009 May 27.

PMID:
19481591
17.

Inhibition of zymosan-induced kidney dysfunction by tyrphostin AG-490.

Dimitrova P, Gyurkovska V, Shalova I, Saso L, Ivanovska N.

J Inflamm (Lond). 2009 May 5;6:13. doi: 10.1186/1476-9255-6-13.

18.

Inflammatory response in patients with active and inactive osteoarthritis.

Toncheva A, Remichkova M, Ikonomova K, Dimitrova P, Ivanovska N.

Rheumatol Int. 2009 Aug;29(10):1197-203. doi: 10.1007/s00296-009-0864-0. Epub 2009 Jan 30.

PMID:
19184030
19.

Tyrphostin AG-490 inhibited the acute phase of zymosan-induced inflammation.

Dimitrova P, Ivanovska N.

Int Immunopharmacol. 2008 Nov;8(11):1567-77. doi: 10.1016/j.intimp.2008.06.013. Epub 2008 Jul 24.

PMID:
18656556
20.

Inhibition of Candida albicans extracellular enzyme activity by selected natural substances and their application in Candida infection.

Yordanov M, Dimitrova P, Patkar S, Saso L, Ivanovska N.

Can J Microbiol. 2008 Jun;54(6):435-40. doi: 10.1139/w08-029.

PMID:
18535628
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk